Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase

Phosphodiesterases 3 and 5 express activity in the trigeminal ganglion and co-localize with calcitonin gene-related peptide

(2013) Julie C Nordgaard et al.   CEPHALALGIA

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

Differences in phosphodiesterase 3A and 3B expression after ischemic insult

(2013) Yumiko Mitome-Mishima et al.   NEUROSCIENCE RESEARCH

Cilostazol Strengthens Barrier Integrity in Brain Endothelial Cells

(2012) Shoji Horai et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries

(2011) Christina Kruuse et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Phosphodiesterase-3B is expressed in proopiomelanocortin and neuropeptide Y neurons in the mouse hypothalamus

(2011) Maitrayee Sahu et al.   NEUROSCIENCE LETTERS

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology

The Science of Stroke: Mechanisms in Search of Treatments

(2010) Michael A. Moskowitz et al.   NEURON

The PACAP receptor: A novel target for migraine treatment

(2010) Henrik W. Schytz et al.   Neurotherapeutics

PACAP38 induces migraine-like attacks in patients with migraine without aura

(2008) Henrik Winther Schytz et al.   BRAIN

Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells

(2008) Jing Li et al.   BRAIN RESEARCH

Cilostazol preserves CA1 hippocampus and enhances generation of immature neuroblasts in dentate gyrus after transient forebrain ischemia in rats

(2008) Jeong Hyun Lee et al.   EXPERIMENTAL NEUROLOGY

VPAC and PAC receptors: From ligands to function

(2008) Louise Dickson et al.   PHARMACOLOGY & THERAPEUTICS